Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study

NCT06909383 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Cancer - Associated Anorexia - Cachexia Syndrome

Interventions

DRUG: Nanocrystalline megestrol acetate

Sponsor

Guangzhou Institute of Respiratory Disease